__MAIN_TEXT__
feature-image

Page 1

®

MOBILE CARDIAC OUTPATIENT TELEMETRY

Superior Detection. Superior Reporting. Validated by Clinical Data.

• • •

Only monitoring device proven to detect AF with 100% sensitivity and 100% positive predictivity in the detection of ≥30-second AF episodes1 Near real-time arrhythmia detection with rate, rhythm, AF with p-wave analysis, and QRS morphology algorithm

ES BETTER 1, 2 monitoring

Proven and published—clinical evidence from 41 MCOT studies, abstracts and articles

MCOT Home Connect Workflow

om six studies e loop recording andSTAF F Registers patient es for mobile cardiac and orders MCOT monitor online metry were adjusted nd time to initiation

COT was used es evaluated

PATIENT

Patient applies MCOT at home

Patient wears near real-time MCOT for up to 30 days Notifications sent per provider protocol

CLI NI CI AN

Baseline report, daily int of study: proportion reports and alerts posted to online portal gnosed with post-stroke for clinician to review and n follow-up with patient †

BIOTEL HEART

Ships MCOT kit to patient's home

PATIENT

Patient returns MCOT kit via pre-paid shipping envelope

CLINICI AN End of Service report provided to clinician to interpret, diagnosis and follow-up with patient

Per provider predetermined protocol

econd AF episodes Now 3Available: QT Prolongation Monitoring for COVID-19 Patients 1

Based on MIT-BIH (Massachusetts Institute of Technology-Beth Israel Hospital) Arrhythmia Database testing of ≥30-second AFib episodes

Profile for BioTel Heart

MCOT Home Connect  

MCOT Home Connect